Trial intelligence / Profile preview

Intranasal dexmedetomidine for postoperative sleep disturbance after laparoscopic surgery

TCTR20261001007Phase 3Not yet recruiting

Sponsor
Department of Anesthesiology
Start
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine in Postoperative sleep disturbance (PSD), sponsored by Department of Anesthesiology. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

Postoperative sleep disturbance (PSD)

Beyond the preview

Go deeper on TCTR20261001007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20261001007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call